Literature DB >> 32442029

Reorganizing Cross-Sectional Interventional Procedures Practice During the Coronavirus Disease (COVID-19) Pandemic.

Ghaneh Fananapazir1, Meghan G Lubner2, Mishal Mendiratta-Lala3, Benjamin Wildman-Tobriner4, Samuel J Galgano5, Ramit Lamba1, J Louis Hinshaw2, Olga R Brook6.   

Abstract

OBJECTIVE. The purpose of this article is to present strategies and guidelines that can be implemented in the performance of cross-sectional interventional procedures during the coronavirus disease (COVID-19) pandemic. CONCLUSION. Radiologists who perform cross-sectional interventional procedures can take several steps to minimize the risks to patients and radiology personnel, including screening referred patients to decide which procedures can be postponed, using appropriate personal protective equipment (PPE), minimizing the number of people involved in procedures, preserving PPE when possible, and applying proper room and equipment cleaning measures.

Entities:  

Keywords:  COVID-19; ablation; biopsy; coronavirus disease; cross-sectional interventional radiology; health care; procedures

Mesh:

Year:  2020        PMID: 32442029     DOI: 10.2214/AJR.20.23227

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Transforming Positive Pressure IR Suites to Treat COVID-19 Patients.

Authors:  Nicole A Lamparello; Sarah Choi; Resmi Charalel; Kyungmouk Steve Lee; Andrew Kesselman; Kimberly Scherer; Christopher M Harnain; William F Browne; Marc Shiffman; Daniel J Holzwanger; Bradley B Pua
Journal:  J Vasc Interv Radiol       Date:  2020-06-30       Impact factor: 3.464

2.  Cross-sectional interventional radiology report.

Authors: 
Journal:  Abdom Radiol (NY)       Date:  2021-02-04

3.  Embolization of a Renal Solid Bleeding Lesion in Intensive Care Unit in a Critically Ill Patient with Severe Acute Respiratory Syndrome-Related Coronavirus Infection and Difficult Mobilization due to Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

Authors:  R Gerasia; G Panarello; R Miraglia
Journal:  Cardiovasc Intervent Radiol       Date:  2022-03-11       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.